Description
Somatrop is a recombinant human growth hormone (HGH), also known as somatropin, produced using recombinant DNA technology. It is structurally identical to endogenous human growth hormone and consists of 191 amino acids. Somatrop is supplied as a sterile solution intended for subcutaneous injection and is commonly referenced in clinical endocrinology and hormone research.
The product is presented as a 100 IU set, containing two vials with a combined content of 33.3 mg of somatropin. Human growth hormone plays a crucial role in normal growth, cellular repair, metabolism, bone density maintenance, and regulation of body composition. In medical settings, recombinant HGH is prescribed for individuals with confirmed growth hormone deficiency and other specific growth-related conditions.
Somatropin acts by binding to growth hormone receptors, initiating signaling pathways that influence protein synthesis, lipid metabolism, and carbohydrate regulation. It also stimulates the production of insulin-like growth factor 1 (IGF-1), a key mediator of many growth hormone effects. These mechanisms are widely documented in medical and scientific literature.
Recombinant human growth hormone is used in pediatric and adult medicine for conditions such as growth hormone deficiency, certain genetic syndromes associated with short stature, and metabolic disorders where GH replacement is clinically indicated. Individual response to somatropin therapy may vary depending on age, health status, hormonal balance, and treatment duration.
Somatrop should not be used in individuals with active malignancies, acute critical illness following major surgery or trauma, or in patients with closed epiphyseal growth plates. Caution is required in individuals with diabetes, thyroid disorders, or cardiovascular disease, and treatment must always be conducted under medical supervision.
Potential side effects discussed in clinical use include fluid retention, joint or muscle discomfort, headache, edema, altered glucose metabolism, and injection-site reactions. Long-term use requires ongoing monitoring to ensure safety and effectiveness.
Somatrop should be stored under recommended conditions, typically refrigerated and protected from light. The solution should remain clear and free of visible particles. Any vial showing signs of contamination or degradation should not be used.
This content is provided strictly for educational and informational purposes and does not replace professional medical advice. Somatrop is a prescription medication affecting endocrine function and should only be used within appropriate medical and regulatory frameworks.